AstraZeneca PLC
Danish weight loss drug maker outlines ambitious 2030 strategy, ramping up pressure on Novo, Lilly
Celsopupo | Istock | Getty Images Zealand Pharma on Thursday outlined an ambitious five-year strategy for its anti-obesity portfolio Thursday, spotlighting how growing competition from smaller players is tightening the race for market leaders Novo Nordisk and Eli Lilly as more of these medicines near market entry. The new strategy, “Metabolic Frontier 2030,” comes as Zealand […]
Read More
These energy stocks are outperforming but underappreciated, according to Goldman Sachs
Power companies caught the attention of Goldman Sachs analysts in November. Ceres Power , Vestas Wind Systems and SSE were among the top performers watched by the investment bank last month. The names come from the bank’s “Conviction List – Directors’ Cut,” a monthly update on stocks it recommends to buy, which is chosen by […]
Read More
U.S. announces zero tariff pharmaceutical deal with Britain
U.S. President Donald Trump and British Prime Minister Keir Starmer hold a press conference following their meeting at Chequers, near Aylesbury, Britain, Sept. 18, 2025. Kevin Lamarque | Reuters The United States announced a deal with Britain for zero tariffs on pharmaceutical products and medical technology on Monday which will lead to Britain spending more […]
Read More
Why Medicare price negotiations matter for Novo Nordisk, AstraZeneca, and other European pharma companies
Drug pricing has emerged as a key topic to watch for pharmaceutical companies and investors in 2025. As President Donald Trump pushes for lower medicine prices for Americans, the sector is facing additional pricing pressure from a Biden-era law called the Inflation Reduction Act. The IRA, voted into law in 2022, allows the Centers for […]
Read More
Three ways for investors to trade the UK Autumn budget
Investors say the pessimism looming over U.K. Finance Minister Rachel Reeves’ crucial Autumn Budget this week masks a range of contrarian opportunities across different sectors and asset classes. Ahead of the chancellor’s critical statement this week — which could herald tax rises, spending cuts, or a combination of the two — fund managers are lining […]
Read More
Trump announces deals with Eli Lilly, Novo Nordisk to slash weight loss drug prices, offer some Medicare coverage
U.S. President Donald Trump attends an event to make an announcement from the Oval Office at the White House in Washington, D.C., U.S. Nov. 6, 2025. Jonathan Ernst | Reuters President Donald Trump on Thursday announced deals with Eli Lilly and Novo Nordisk to slash the prices of some of their obesity drugs, including upcoming […]
Read More
European stocks lose ground as earnings hold the spotlight; Rheinmetall gains 2%
The City of London skyline at sunset. Gary Yeowell | Digitalvision | Getty Images LONDON — European stocks edged lower on Thursday, as investors reacted to another flurry of corporate earnings. The pan-European Stoxx 600 was down 0.07% as of 11:26 a.m. in London (6:26 a.m. ET), with most sectors and major bourses in negative […]
Read More
European markets start the new trading month higher
An aerial view of the Shard on June 28, 2012 in London, England. Greg Fonne/Getty Images LONDON — European stocks opened the new trading week — and month — on a positive note ahead of a busy week of central bank decisions and earnings. The pan-European Stoxx 600 opened just above the flatline. The U.K.’s […]
Read More
Merck tops estimates on Keytruda strength and narrows profit outlook, as it lowers estimated tariff hit
Merck on Thursday reported third-quarter earnings and revenue that topped estimates as it saw strong demand for its cancer immunotherapy Keytruda. The drugmaker also narrowed its full-year profit outlook to reflect lower estimated tariff costs, among other factors. Sales of Keytruda topped $8 billion for the first time in a quarter, rising 10% from the […]
Read More
ServiceNow CEO denies AI companies are threatening enterprise software: ‘They don’t do what we do’
ServiceNow CEO Bill McDermott pushed back against the idea that artificial intelligence technology will make enterprise software redundant in a Wednesday interview with CNBC’s Jim Cramer. “We realize the world needs access to the great hyperscalers, and so we integrated with all three of them. So that’s a cooperative,” McDermott said. “The world’s going to […]
Read More